Results 41 to 50 of about 2,102 (205)

Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by Trypanosoma congolense Infection

open access: yesPathogens, 2022
Animal African trypanosomosis (AAT) leads to emaciation and low productivity in infected animals. Only six drugs are commercially available against AAT; they have severe side effects and face parasite resistance.
Keisuke Suganuma   +7 more
doaj   +1 more source

Estimating the impact of Trypanosoma evansi infection (surra) on buffalo population dynamics in southern Philippines using data from cross-sectional surveys

open access: yes, 2009
Despite the widespread problem with surra (Trypanosoma evansi) in livestock, there are no published studies on its impact on host populations, probably because of the large financial and time cost involved in performing longitudinal studies.
Dargantes, A.P.   +7 more
core   +1 more source

Trypanosome à T. evansi (Surra)

open access: yes, 2013
1. Rappel La trypanosomose à Trypanosoma evansi ou maladie du Surra est une maladie réglementée en France (maladie légalement réputée contagieuse) des dromadaires, équidés, ruminants (bovins, buffles...), carnivores...

core   +2 more sources

Trypanosoma evansi is alike to Trypanosoma brucei brucei in the subcellular localisation of glycolytic enzymes

open access: yesMemorias do Instituto Oswaldo Cruz, 2015
Trypanosoma evansi, which causes surra, is descended from Trypanosoma brucei brucei, which causes nagana. Although both parasites are presumed to be metabolically similar, insufficient knowledge of T. evansi precludes a full comparison.
S Andrea Moreno, Mayerly Nava
doaj   +1 more source

In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 138, Issue 5, May 2026.
ABSTRACT Plant extracts are an important raw material for the development of new drugs. Rumex obtusifolius L., popularly known as ‘bitter dock’, has significant pharmacological properties. This study evaluated the in vitro antitrypanosomal activity of aqueous, hydroethanolic and ethanolic extracts from the leaf and roots of R. obtusifolius L.
Gabriela K. Borges   +5 more
wiley   +1 more source

Potential entry pathways for 25 vector‐borne disease agents

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA)   +7 more
wiley   +1 more source

Surra: Trypanosomiasis in Livestock is Potential as Zoonotic Disease

open access: yes, 2018
Trypanosoma evansi is one of blood protozoans having the most wide distribution region compared to other Trypanosome species. The parasite causes trypanosomiasis known as Surra. The disease may cause mortality to the infected animals. In general T evansi
Savitri, Dyah H, Wardhana, April Hari
core   +1 more source

Parasitological, serological and molecular survey of Trypanosoma evansi infection in dromedary camels from Cholistan Desert, Pakistan

open access: yesParasites & Vectors, 2015
Background Surra, a vector borne disease caused by Trypanosoma (T.) evansi, affects the health, productivity and working capacity of camels. Since clinical signs are not pathognomonic, diagnosis must be confirmed by laboratory methods.
Sonia Tehseen   +6 more
doaj   +1 more source

Identification and mapping of potential and highly likely vectors for selected vector‐borne diseases in the EU and neighbouring countries

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract This report addresses Term of Reference 1.2 by providing a comprehensive knowledge‐mapping of arthropod vector species competent to transmit selected vector‐borne diseases (VBDs) including VBDs listed under Regulation (EU) 2016/429 and Regulation (EU) 2020/687, as well as additional non‐listed pathogens with potential epidemiological relevance.
European Food Safety Authority (EFSA)   +7 more
wiley   +1 more source

Vector‐borne diseases‐knowledge maps

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract This scientific report provides a structured overview of the main characteristics of 25 selected vector‐borne diseases (VBDs) of potential relevance for the EU, including 12 diseases listed under the Animal Health Law (AHL) and 13 non‐listed diseases.
European Food Safety Authority (EFSA)   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy